What can we learn by studying microbial communities at different body sites?
"The human microbiota is a fundamental component of what it means to be human," says David Relman in a recent JAMA opinion piece. In this article, Relman gives a picture of the importance of the human microbiota in health and a brief history of how scientists have measured it.
“The human microbiota is a fundamental component of what it means to be human,” says David Relman in a recent JAMA opinion piece. In this article, Relman gives a picture of the importance of the human microbiota in health and a brief history of how scientists have measured it.
Relman names body site as one of the strongest determinants of microbiome diversity variation, perhaps because of the different selective pressures at each site. He says that by learning more about the features of microbiota structure and function in each “ecological zone” of the human body (including the gut), scientists may be able to detect early markers of local disease.
Relman cites evidence that small molecules may promote stability of microbial communities by mediating interactions among community members. Some stable states are associated with health, and others with disease. Furthermore, communities that lack resilience — i.e. the ability of a complex system to return to its original structure following a stress/challenge — could be vulnerable to environmental factors such as antibiotics. To better understand these dynamics, Relman calls for studies with more dense temporal and spatial sampling of microbial communities.
Relman DA. (2015) The human microbiome and the future practice of medicine. JAMA doi:10.1001/jama.2015.10700
Head of the Gastrointestinal Research Section at the Hospital General Vall d’Hebron in Barcelona, Spain, since 1987, he currently serves as Chair of the Gut Microbiota & Health section of the European Society of Neurogastroenterology and Motility. Prof. Aspiroz’s clinical practice takes place in a large referral unit and specifically focuses on functional gut disorders. His research programme investigates the origin of gastrointestinal symptoms and involves both physiological and pathophysiological aspects relating to the control mechanisms of gut motility, visceral sensitivity and more recently, intestinal gas dynamics.
Studies over the last decade have brought new hope that gut microbiome-targeted therapeutics might offer novel treatments for obesity. In this post, we ask whether dietary interventions, prebiotics, probiotics and medication that target the microbiome are useful for weight management.
The 11th Gut Microbiota for Health World Summit focused on emerging gut microbiome-targeted treatments in digestive, immune and cardiometabolic health. This post highlights the major take-aways from the conference and explores how they might impact clinical practice in the foreseeable future.
Following the GMFH 2022 Year at a Glance report, it is time for a flashback in the latest research on cancer microbiome. This post ranges between the epidemiology, etiology and diagnosis of cancer, looking at the role of fungal and bacterial gut microbiome in all three health care branches.